StockDriftsStockDriftsTop 13 Aisling Capital Management LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma Inc. (BBIO) | 79.35% | 5.09M | $378.0M | +0.00%(+0) | $40.61(+90.06%) | 2026-03-31 | |
| SNDX | Syndax Pharmaceuticals, Inc. (SNDX) | 6.46% | 1.32M | $30.8M | +0.00%(+0) | $10.51(+107.64%) | 2026-03-31 | |
| GLUE | Monte Rosa Therapeutics Inc (GLUE) | 5.37% | 1.56M | $25.6M | +5.66%(+83.33K) | $22.34(+8.35%) | 2026-03-31 | |
| BCAX | Bicara Therapeutics Inc. (BCAX) | 2.38% | 568.9K | $11.3M | +0.00%(+0) | $25.47(+13.86%) | 2026-03-31 | |
| BBOT | BridgeBio Oncology Therapeutics (BBOT) | 1.91% | 1.02M | $9.1M | +80.30%(+453.39K) | $10.94(-25.85%) | 2026-03-31 | |
| CMPS | Compass Pathways Plc (CMPS) | 1.66% | 1.43M | $7.9M | +19.52%(+233.92K) | $6.84(+99.23%) | 2026-03-31 | |
| SRRK | Scholar Rock Holding Corporation (SRRK) | 0.8% | 77.0K | $3.8M | +0.00%(+0) | $36.33(+51.06%) | 2026-03-31 | |
| BMEA | Biomea Fusion Inc (BMEA) | 0.66% | 2.05M | $3.1M | +0.00%(+0) | $7.34(-80.78%) | 2026-03-31 | |
| EPRX | Eupraxia Pharmaceuticals Inc. (EPRX) | 0.49% | 325.0K | $2.4M | new | $7.39(-9.53%) | 2026-03-31 | |
| URGN | Urogen Pharma Ltd. (URGN) | 0.41% | 108.0K | $1.9M | +0.00%(+0) | $21.69(+75.33%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +41.23% | +181.70% |
| Top 20 Holdings Unweighted | +22.97% | +85.93% |
Sign up free to track Aisling Capital Management LP, compare funds side by side, and get alerts the moment positions change.